Paper9469682
A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.
Bieniek SA and 3 others. Pharmacotherapy, 1998. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Papers, record 9469682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9469682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aggression | Major topic |
| Antipsychotic Agents | Major topic |
| Haloperidol | Major topic |
| Lorazepam | Major topic |
| Psychotic Disorders | Major topic |
| Adult | |
| Behavioral Symptoms | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40032552 | Chronotherapeutic considerations of benzodiazepine administration for agitation management in the emergency department. | BMJ Ment Health | 2025 | https://conductscience.org/library/papers/40032552 | PubMed |
| 37313488 | Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19. | J Alzheimers Dis Rep | 2023 | https://conductscience.org/library/papers/37313488 | PubMed |
| 33692709 | Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/33692709 | PubMed |
| 32352565 | Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32352565 | PubMed |
| 31890361 | Treatment Options for Acute Agitation in Psychiatric Patients: Theoretical and Empirical Evidence. | Cureus | 2019 | https://conductscience.org/library/papers/31890361 | PubMed |
| 31681100 | Effectiveness of Electroacupuncture and Electroconvulsive Therapy as Additional Treatment in Hospitalized Patients With Schizophrenia: A Retrospective Controlled Study. | Front Psychol | 2019 | https://conductscience.org/library/papers/31681100 | PubMed |
| 31431244 | The Use of Rapid Tranquilization in Aggressive Behavior. | Dtsch Arztebl Int | 2019 | https://conductscience.org/library/papers/31431244 | PubMed |
| 30843960 | Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach. | Braz J Psychiatry | 2019 | https://conductscience.org/library/papers/30843960 | PubMed |
| 29219171 | Benzodiazepines for psychosis-induced aggression or agitation. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29219171 | PubMed |
| 28758203 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28758203 | PubMed |
| 27022468 | Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study. | Pharmacol Res Perspect | 2015 | https://conductscience.org/library/papers/27022468 | PubMed |
| 26187543 | [Pharmacotherapy of psychiatric acute and emergency situations: General principles]. | Nervenarzt | 2015 | https://conductscience.org/library/papers/26187543 | PubMed |
| 24221620 | [Psychopharmacotherapy in emergency medicine]. | Med Klin Intensivmed Notfmed | 2013 | https://conductscience.org/library/papers/24221620 | PubMed |
| 23152236 | Benzodiazepines for schizophrenia. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/23152236 | PubMed |
| 21691475 | Excited delirium. | West J Emerg Med | 2011 | https://conductscience.org/library/papers/21691475 | PubMed |
| 18278976 | Pharmacological control of acute agitation: focus on intramuscular preparations. | CNS Drugs | 2008 | https://conductscience.org/library/papers/18278976 | PubMed |
| 16699602 | The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. | J Psychiatry Neurosci | 2006 | https://conductscience.org/library/papers/16699602 | PubMed |
| 16080423 | Review of benzodiazepine use in children and adolescents. | Psychiatr Q | 2005 | https://conductscience.org/library/papers/16080423 | PubMed |
| 15916448 | Pharmacological management of acute agitation. | Drugs | 2005 | https://conductscience.org/library/papers/15916448 | PubMed |
| 12898042 | [Psychopharmacological treatment in the pre-clinical emergency medicine]. | Anaesthesist | 2003 | https://conductscience.org/library/papers/12898042 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9469682
GET https://conductscience.org/api/papers/v1/9469682/cited_by?page=2